Incidence trends and clinical–pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the Canton of Zurich, Switzerland

The aims of this paper are to describe the incidence trends of invasive cutaneous melanoma in the Canton of Zurich and to evaluate clinical and pathological factors such as cancer subtype, localization, age and Breslow thickness. A retrospective analysis was carried out with data from the population-based Cancer Registry of Zurich and Zug located in Zurich. A total of 8469 cases in 8034 different patients of invasive cutaneous melanoma were registered for the period 1980–2010 in the Canton of Zurich. Incidence trends were age standardized to the European standard population. Joinpoint regression was used to compute changes in incidence and mortality rates, measured as the annual percent change (APC). The most common subtypes of cutaneous melanoma were superficial spreading melanoma (SSM, 41.1%), followed by nodular melanoma (16.5%), lentigo maligna melanoma (13.5%), acral-lentiginous melanoma (5.0%) and other types of melanoma (2.8%); 21.1% were melanoma not otherwise specified. The trunk was the most frequent location (30.8%), followed by the lower limb and hip (26.4%) and the upper limb and shoulder (22.8%). Statistically significantly increasing incidence trends were observed for both men (APC=3.0%) and women (APC=2.1%). Incidences of SSM and melanoma not otherwise specified were the histological subtypes for which a significant increase in incidence was observed (APC for the period 1980–2010=3.2% for both). In terms of Breslow thickness, thin melanomas (0.01–1.00 mm) showed an increasing incidence. The incidence of melanoma increased in both men and women between 1980 and 2010. In terms of the different subtypes and Breslow thickness, increasing incidences of the SSM and of thin melanomas (0.01–1.00 mm) were observed. These observations are in agreement with other studies from Southern and Western Switzerland as well as other European countries and the USA.

[1]  Tim K. Lee,et al.  Melanoma Epidemiology and Prevention. , 2016, Cancer treatment and research.

[2]  V. de Giorgi,et al.  Melanoma density and relationship with the distribution of melanocytic naevi in an Italian population: a GIPMe study — the Italian multidisciplinary group on melanoma , 2015, Melanoma research.

[3]  L. Mazzucchelli,et al.  Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence , 2013, Melanoma research.

[4]  J. Ferlay,et al.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. , 2013, European journal of cancer.

[5]  J. Ferlay,et al.  Global estimates of cancer prevalence for 27 sites in the adult population in 2008 , 2013, International journal of cancer.

[6]  B. Møller,et al.  Sex differences in rising trends of cutaneous malignant melanoma in Norway, 1954–2008 , 2013, Melanoma research.

[7]  J. Moan,et al.  Superficial-spreading and nodular melanomas in Norway: a comparison by body site distribution and latitude gradients , 2012, Melanoma research.

[8]  J. Paoli,et al.  Incidence of cutaneous melanoma in Western Sweden, 1970–2007 , 2012, Melanoma research.

[9]  M. Weinstock,et al.  The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007. , 2012, Archives of dermatology.

[10]  R. Merrill Risk-adjusted melanoma skin cancer incidence rates in Whites (United States) , 2011, Melanoma research.

[11]  D. Godar Worldwide Increasing Incidences of Cutaneous Malignant Melanoma , 2011, Journal of skin cancer.

[12]  M. Kukushkina,et al.  P028. Epidemiology of skin melanoma in Ukraine , 2011 .

[13]  M. Zappa,et al.  The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past , 2010, Melanoma research.

[14]  Esther de Vries,et al.  Incidence and trends of cutaneous malignancies in the Netherlands, 1989-2005. , 2010, The Journal of investigative dermatology.

[15]  D. Whiteman Melanoma screening: The Australian perspective , 2010 .

[16]  T. Nijsten,et al.  FC5 Incidence and trends of cutaneous malignancies in The Netherlands, 1989–2005 , 2010 .

[17]  J. Q. Rosso,et al.  Acral Lentiginous Melanoma: Incidence and Survival Patterns in the United States, 1986-2005 , 2010 .

[18]  A. Kimball,et al.  Accessibility to air travel correlates strongly with increasing melanoma incidence* , 2006, Melanoma research.

[19]  P. Leboit Pathology and genetics of skin tumours , 2006 .

[20]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[21]  C. Vecchia,et al.  Trends in incidence of various morphologies of malignant melanoma in Vaud and Neuchâtel, Switzerland , 2005, Melanoma research.

[22]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[23]  P. Boyle,et al.  Cancer registration: principles and methods. Statistical methods for registries. , 1991, IARC scientific publications.

[24]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .